13F HOLDINGS REPORT
Crestline Management, LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001315863-26-000165
Total Value
$53.3M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DENALI THERAPEUTICS INC | DNLI | 2,810,732 | $46.4M | 87.02% |
| 2 | SANA BIOTECHNOLOGY INC | SANA | 1,220,937 | $5.0M | 9.32% |
| 3 | 8X8 INC NEW | 282914100 | 990,580 | $2.0M | 3.66% |